ADMA Biologics reported FY 2024 revenue of $426.5 million, achieving significant increases in net income and adjusted EBITDA. ADMA Biologics, Inc. reported strong financial results for FY 2024, ...
Antalpha reports a 41% revenue increase and 423% net income growth in Q1 2025, exploring new digital asset lending avenues. Antalpha Platform Holding Company, a fintech provider for the Bitcoin mining ...
(3) Represents net losses and loss adjustment expenses of $15.8 million less tax benefit of $3.5 million. (4) See previous table for reconciliation of operating income (loss) to net income (loss) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results